Phlebitis. Vascular complications following infusion, transfusion and therapeutic injection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Consciousness & Patient cooperation Age between 25-75 years Admitted to hospital with Gastrointestinal cancer (colon, rectum, esophagus, stomach) Chemotherapeutic management with 5-fluorouracil & Oxaloplatin & Leukovein or 5-fluorouracil & Cisplatin Catheterization into arm vein Application No. 20-22 catheter Unicut Company Instructions no received antibiotic & Non-steroidal anti-inflammatory drugs Without diabetes, Skin disorders and Autoimmune diseases Stable hemodynamic status Not addiction Hospitalized in the Oncology Ward of Tohid Hospital Without fever & neutropenia
Exclusion criteria
Exclusion criteria: Unwillingness to be in the study Worsen the condition of patient during the study Incidence of allergic reactions during the study Acute infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phlebitis. Timepoint: Every 12 hours over 72 hours after intervention. Method of measurement: observation, Visual Infusion Phlebitis Scale ( VIP). | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain, Erythema and Swelling. Timepoint: Every 12 hours over 72 hours. Method of measurement: Observation, Visual infusion phlebitis Scale (VIP). | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University